{{Rsnum
|rsid=6413453
|Gene=APOA2
|Chromosome=1
|position=161222526
|Orientation=minus
|GMAF=0.1074
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=APOA2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 72.6 | 27.4 | 0.0
| HCB | 77.4 | 19.7 | 2.9
| JPT | 49.6 | 41.6 | 8.8
| YRI | 98.0 | 2.0 | 0.0
| ASW | 87.7 | 12.3 | 0.0
| CHB | 77.4 | 19.7 | 2.9
| CHD | 75.2 | 24.8 | 0.0
| GIH | 67.3 | 27.7 | 5.0
| LWK | 99.1 | 0.9 | 0.0
| MEX | 79.3 | 17.2 | 3.4
| MKK | 97.4 | 2.6 | 0.0
| TSI | 81.4 | 15.7 | 2.9
| HapMapRevision=28
}}A meta-analysis of several [[APOA2]] SNPs (including this one) found no association between any APOA2 SNPs studied and type-2 diabetes.{{PMID|19216768|OA=1
}}

{{PMID Auto
|PMID=18269685
|Title=Type 2 diabetes susceptibility genes on chromosome 1q21-24.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}